- Home
- HUHU vs HLVX Comparison
HUHU vs HLVX Comparison
Compare HUHU & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUHU
- HLVX
- Stock Information
- Founded
- HUHU 2015
- HLVX 2020
- Country
- HUHU China
- HLVX United States
- Employees
- HUHU N/A
- HLVX N/A
- Industry
- HUHU
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- HUHU
- HLVX Health Care
- Exchange
- HUHU NYSE
- HLVX Nasdaq
- Market Cap
- HUHU 86.8M
- HLVX 93.1M
- IPO Year
- HUHU 2024
- HLVX 2022
- Fundamental
- Price
- HUHU $4.56
- HLVX $1.90
- Analyst Decision
- HUHU
- HLVX Hold
- Analyst Count
- HUHU 0
- HLVX 5
- Target Price
- HUHU N/A
- HLVX $2.33
- AVG Volume (30 Days)
- HUHU 57.2K
- HLVX 295.6K
- Earning Date
- HUHU 02-22-2025
- HLVX 11-07-2024
- Dividend Yield
- HUHU N/A
- HLVX N/A
- EPS Growth
- HUHU 13.14
- HLVX N/A
- EPS
- HUHU 0.08
- HLVX N/A
- Revenue
- HUHU $17,492,735.00
- HLVX N/A
- Revenue This Year
- HUHU N/A
- HLVX N/A
- Revenue Next Year
- HUHU N/A
- HLVX N/A
- P/E Ratio
- HUHU $55.65
- HLVX N/A
- Revenue Growth
- HUHU 33.03
- HLVX N/A
- 52 Week Low
- HUHU $3.52
- HLVX $1.55
- 52 Week High
- HUHU $9.89
- HLVX $20.22
- Technical
- Relative Strength Index (RSI)
- HUHU N/A
- HLVX 42.75
- Support Level
- HUHU N/A
- HLVX $1.87
- Resistance Level
- HUHU N/A
- HLVX $1.98
- Average True Range (ATR)
- HUHU 0.00
- HLVX 0.08
- MACD
- HUHU 0.00
- HLVX -0.02
- Stochastic Oscillator
- HUHU 0.00
- HLVX 10.71
About HUHU HUHUTECH INTL GROUP INC
HUHUTECH International Group Inc specializes in providing factory facility management and monitoring systems, including high-purity gas, chemicals and liquid system and factory management and control systems for industrial clients, who are mainly semi-conductor manufacturers and electronics manufacturers in China. The products and services are widely used by semi-conductor manufacturers, LED and micro-electronics factories, as well as some pharmaceutical, food and beverage manufacturers.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.